Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study
Healey, Jeff S, Dr, Oldgren, Jonas, MD, Ezekowitz, Michael, Prof, Zhu, Jun, MD, Pais, Prem, Prof, Wang, Jia, Msc, Commerford, Patrick, MD, Jansky, Petr, MD, Avezum, Alvaro, MD, Sigamani, Alben, MD, Demasceno, Albertino, MD, Reilly, Paul, PhD, Grinvalds, Alex, BSc, Nakamya, Juliet, PhD, Aje, Akinyemi, MD, Almahmeed, Wael, MD, Moriarty, Andrew, MD, Wallentin, Lars, Prof, Yusuf, Salim, Prof, Connolly, Stuart J, Prof
Published in The Lancet (British edition) (17.09.2016)
Published in The Lancet (British edition) (17.09.2016)
Get full text
Journal Article
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Wallentin, Lars, Prof, Yusuf, Salim, Prof, Ezekowitz, Michael D, Prof, Alings, Marco, MD, Flather, Marcus, MD, Franzosi, Maria Grazia, PhD, Pais, Prem, Prof, Dans, Antonio, Prof, Eikelboom, John, MD, Oldgren, Jonas, MD, Pogue, Janice, PhD, Reilly, Paul A, PhD, Yang, Sean, MSc, Connolly, Stuart J, Prof
Published in The Lancet (British edition) (18.09.2010)
Published in The Lancet (British edition) (18.09.2010)
Get full text
Journal Article
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation
Aulin, Julia, MD, Siegbahn, Agneta, MD, PhD, Hijazi, Ziad, MD, PhD, Ezekowitz, Michael D., MB, ChB, Andersson, Ulrika, MSc, Connolly, Stuart J., MD, Huber, Kurt, MD, PhD, Reilly, Paul A., PhD, Wallentin, Lars, MD, PhD, Oldgren, Jonas, MD, PhD
Published in The American heart journal (01.12.2015)
Published in The American heart journal (01.12.2015)
Get full text
Journal Article
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
Ezekowitz, Michael D., MBChB, DPhil, Connolly, Stuart, MD, Parekh, Amit, MD, Reilly, Paul A., PhD, Varrone, Jeanne, MD, Wang, Susan, PhD, Oldgren, Jonas, MD, PhD, Themeles, Ellison, Wallentin, Lars, MD, PhD, Yusuf, Salim, FRCP(c), FRSC, DPhil
Published in The American heart journal (01.05.2009)
Published in The American heart journal (01.05.2009)
Get full text
Journal Article
Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation
Eikelboom, John W., MBBS, Connolly, Stuart J., MD, Hart, Robert G., MD, Wallentin, Lars, MD, PhD, Reilly, Paul, PhD, Oldgren, Jonas, MD, PhD, Yang, Sean, MSc, Yusuf, Salim, MD, DPhil
Published in Journal of the American College of Cardiology (03.09.2013)
Published in Journal of the American College of Cardiology (03.09.2013)
Get full text
Journal Article
Apixaban compared with parenteral heparin and or Vitamin K antagonist in patients with non-valvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE Trial
Ezekowitz, Michael D., MBChB, DPhil, Pollack, Charles V., MD, MA, Sanders, Paul, PhD, Halperin, Jonathan L., MD, Spahr, Judith, MPH, MEd, Cater, Nilo, MD, Petkun, William, MD, Breazna, Andrei, PhD, Kirchhof, Paulus, MD, Oldgren, Jonas, MD, PhD
Published in The American heart journal (2015)
Published in The American heart journal (2015)
Get full text
Journal Article
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome
Eggers, Kai M., MD, PhD, Lagerqvist, Bo, MD, PhD, Oldgren, Jonas, MD, PhD, Venge, Per, MD, PhD, Wallentin, Lars, MD, PhD, Lindahl, Bertil, MD, PhD
Published in The American heart journal (01.09.2008)
Published in The American heart journal (01.09.2008)
Get full text
Journal Article
Xa inhibition and coagulation activity—the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals
Oldgren, Jonas, MD, PhD, Johnston, Nina, MD, PhD, Siegbahn, Agneta, MD, PhD
Published in The American heart journal (01.03.2008)
Published in The American heart journal (01.03.2008)
Get full text
Journal Article
Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention
Åkerblom, Axel, MD, James, Stefan K., MD, PhD, Koutouzis, Michail, MD, PhD, Lagerqvist, Bo, MD, PhD, Stenestrand, Ulf, MD, PhD, Svennblad, Bodil, PhD, Oldgren, Jonas, MD, PhD
Published in Journal of the American College of Cardiology (03.08.2010)
Published in Journal of the American College of Cardiology (03.08.2010)
Get full text
Journal Article
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial
Tangelder, Marco J.D., MD, PhD, Frison, Lars, PhD, Weaver, Douglas, MD, PhD, Wilcox, Robbert G., MD, PhD, Bylock, Anders, MD, PhD, Emanuelsson, Håkan, MD, PhD, Held, Peter, MD, PhD, Oldgren, Jonas, MD, PhD
Published in The American heart journal (01.02.2008)
Published in The American heart journal (01.02.2008)
Get full text
Journal Article